Research Group for Gut Microbiome and Health (RGGMH) at Guangdong Institute of Microbiology was established by Dr. Liwei Xie and funded by grants from Guangdong Academy of Sciences and Guangdong Institute of Microbiology. Dr. Liwei Xie was trained in the area of both Molecular Nutrition and Computational Biology in United States in 2007-2017. The research group focuses on the AI-algorithm development and application in drug design, functional and health benefit small molecules and nature products design and screening, targeting gut microbial dysbiosis-associated metabolic diseases, such as Type 2 diabetes (T2D) and obesity. Our group has state of art research facilities including high-throughput screening and computation system, single cell screening, isolation and sequencing system, health and disease related transgenic mice and gut microbiome models. We aim to provide basic biomedical training not only for graduate students and postdoctoral researchers, but also for clinical students and doctors with respect to the translational studies.